Declining β-cell function in type 2 diabetes: 5-Year follow-up and immunologic studies of the population of Wadena, MN

Metabolism: Clinical and Experimental

Volumn 51, Issue 2, 2002, Pages 144-148

  Goetz, Frederick C ^a,b,c   Roel, Joseph ^a,b,c   Jacobs, David R ^a,b,c   Barbosa, Jose ^a,b,c   Hannan, Peter ^a,b,c   Palmer, Jerry ^a,b,c   Hagopian, William ^a,b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; CREATININE; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CREATININE CLEARANCE; DISEASE DURATION; EUROPE; FEMALE; FOLLOW UP; GEOGRAPHIC ORIGIN; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMMUNOASSAY; IMMUNOLOGICAL MONITORING; IMPAIRED GLUCOSE TOLERANCE; INSULIN METABOLISM; INSULIN RELEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN URINE LEVEL; STIMULUS RESPONSE; UNITED STATES; URINALYSIS;

EID: 0036176736     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.29974     Document Type: Article

References (28)

1. Pathogenesis of NIDDM: A balanced overview
2. Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects
3. U.K. Prospective Diabetes Study 16: Overview of 6 years' therapy of type II diabetes: A progressive disease
4. The classification of diabetes by clinical and C-peptide criteria. A prospective population-based study
5. The potential usefulness of postprandial urine C-peptide measurement in classifying diabetic patients
6. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota
7. Clinical and pathogenic significance of pancreatic islet-cell antibodies in diabetics treated with oral hypoglycemic agents
8. Predictive value of insulin autoantibodies for further progression of beta cell dysfunction in non-insulin-dependent diabetics
9. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease
10. Population-based study of impaired glucose tolerance and type II diabetes in Wadena, Minnesota
11. Association between stimulated plasma C-peptide and age: The Wadena City Health Study
12. Risk factors for kidney damage in the adult population of Wadena, Minnesota
13. Determinants of the glomerular filtration of macromolecules
14. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
15. Report of a WHO study group
16. Radioimmunological determination of human C-peptide in serum
17. Determination of glycosylated hemoglobin by affinity chromatography: Comparison with colorimetric and ion-exchange methods, and effects of common interferences
18. Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop
19. Increased specificity and sensitivity of insulin antibody measurements in autoimmune thyroid disease and type I diabetes
20. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children
21. High level of concordance between assays for GADAb: The first international GADAb workshop
22. Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine
23. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents
24. Prevalence of insulin deficiency among initially non-insulin-dependent middle-aged diabetic individuals
25. IRI secretion in MOD with and without SU (5 year control)
26. Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment
27. Genetic and immunologic findings in patients with newly diagnosed insulin-dependent diabetes mellitus. The Swedish Childhood Diabetes Study Group and The Diabetes Incidence in Sweden Study (IDISS)
28. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes